These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32571761)
21. The combined use of Drug-eluting balloon and Excimer laser for coronary artery Restenosis In-Stent Treatment: The DERIST study. Ambrosini V; Golino L; Niccoli G; Roberto M; Lisanti P; Ceravolo R; Bernardi G; Armigliato P; Gabrielli G; Chizzola G; De Paulis C; Crea F; Colombo A Cardiovasc Revasc Med; 2017; 18(3):165-168. PubMed ID: 28081977 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis. Almalla M; Pross V; Marx N; Hoffmann R Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414 [TBL] [Abstract][Full Text] [Related]
23. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942 [TBL] [Abstract][Full Text] [Related]
24. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C; JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776 [TBL] [Abstract][Full Text] [Related]
25. Rotational Atherectomy for the Management of Undilatable In-Stent Restenosis with Single or Multiple Stent Layers. Yasumura K; Ueyama H; Jeffrey S; Vengrenyuk Y; Barman N; Suleman J; Kini AS; Sharma SK Cardiovasc Revasc Med; 2022 Jan; 34():32-37. PubMed ID: 33514489 [TBL] [Abstract][Full Text] [Related]
26. Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis. Varghese MJ; Bhatheja S; Baber U; Kezbor S; Chincholi A; Chamaria S; Buckstein M; Bakst R; Kini A; Sharma S Circ Cardiovasc Interv; 2018 Oct; 11(10):e006832. PubMed ID: 30354630 [TBL] [Abstract][Full Text] [Related]
27. The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions. Li H; Ai H; Li L; Zheng N; Tang G; Yang G; Zhao Y; Sun F; Zhang H BMC Cardiovasc Disord; 2021 Aug; 21(1):399. PubMed ID: 34407770 [TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289 [TBL] [Abstract][Full Text] [Related]
29. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660 [TBL] [Abstract][Full Text] [Related]
30. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience. Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683 [TBL] [Abstract][Full Text] [Related]
31. The initial course of in-stent restenosis influences the response to vascular brachytherapy. Cheneau E; Leborgne L; Wolfram R; Dilcher C; Pakala R; Pichard AD; Satler LF; Canos D; Lindsay J; Waksman R Cardiovasc Radiat Med; 2002; 3(2):102-6. PubMed ID: 12699840 [TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice. Nikas DN; Kalef-Ezra J; Katsouras CS; Tsekeris P; Bozios G; Pappas C; Naka KK; Kotsia A; Papamichael N; Sideris DA; Michalis LK Int J Cardiol; 2007 Feb; 115(2):183-9. PubMed ID: 16890309 [TBL] [Abstract][Full Text] [Related]
33. The state of the excimer laser for coronary intervention in the drug-eluting stent era. Badr S; Ben-Dor I; Dvir D; Barbash IM; Kitabata H; Minha S; Pendyala LK; Loh JP; Torguson R; Pichard AD; Waksman R Cardiovasc Revasc Med; 2013; 14(2):93-8. PubMed ID: 23332778 [TBL] [Abstract][Full Text] [Related]
34. Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography. Miyazaki T; Ashikaga T; Fukushima T; Hatano Y; Sasaoka T; Kurihara K; Ono Y; Shimizu S; Otomo K; Hirao K J Interv Cardiol; 2019; 2019():6515129. PubMed ID: 31772538 [TBL] [Abstract][Full Text] [Related]
35. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis. Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Clinical Results Following the Use of Drug-Eluting Balloons for a Bare-Metal Stent and Drug-Eluting Stent Instent Restenosis. Lee WC; Fang YN; Fang CY; Chen CJ; Yang CH; Yip HK; Hang CL; Wu CJ; Fang HY J Interv Cardiol; 2016 Oct; 29(5):469-479. PubMed ID: 27501848 [TBL] [Abstract][Full Text] [Related]
37. Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial. Wiemer M; König A; Rieber J; Sohn HY; Leibig M; Theisen K; Klauss V; Langer C; Lindner O; Horstkotte D; Schiele TM EuroIntervention; 2011 Jan; 6(6):687-94. PubMed ID: 21205590 [TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis. Maluenda G; Ben-Dor I; Gaglia MA; Wakabayashi K; Mahmoudi M; Sardi G; Laynez-Carnicero A; Torguson R; Xue Z; Margulies AD; Suddath WO; Kent KM; Bernardo NL; Satler LF; Pichard AD; Waksman R Circ Cardiovasc Interv; 2012 Feb; 5(1):12-9. PubMed ID: 22319069 [TBL] [Abstract][Full Text] [Related]
39. Excimer laser coronary angioplasty and intracoronary radiation for in-stent restenosis: six-month angiographic and clinical outcomes. Ajani AE; Waksman R; Kim HS; Satler LF; Pichard AD; Kent KM; Porrazzo M; White RL; Pinnow EE; Lindsay JR Cardiovasc Radiat Med; 2001; 2(3):191-6. PubMed ID: 11786326 [TBL] [Abstract][Full Text] [Related]